{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:36:47Z","timestamp":1788583007792,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["NSF ACI-1429467\/RUI-1904797"],"award-info":[{"award-number":["NSF ACI-1429467\/RUI-1904797"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["XSEDE MCB 170088"],"award-info":[{"award-number":["XSEDE MCB 170088"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>RNA dependent RNA polymerase (RdRp), is an essential in the RNA replication within the life cycle of the severely acute respiratory coronavirus-2 (SARS-CoV-2), causing the deadly respiratory induced sickness COVID-19. Remdesivir is a prodrug that has seen some success in inhibiting this enzyme, however there is still the pressing need for effective alternatives. In this study, we present the discovery of four non-nucleoside small molecules that bind favorably to SARS-CoV-2 RdRp over the active form of the popular drug remdesivir (RTP) and adenosine triphosphate (ATP) by utilizing high-throughput virtual screening (HTVS) against the vast ZINC compound database coupled with extensive molecular dynamics (MD) simulations. After post-trajectory analysis, we found that the simulations of complexes containing both ATP and RTP remained stable for the duration of their trajectories. Additionally, it was revealed that the phosphate tail of RTP was stabilized by both the positive amino acid pocket and magnesium ions near the entry channel of RdRp which includes residues K551, R553, R555 and K621. It was also found that residues D623, D760, and N691 further stabilized the ribose portion of RTP with U10 on the template RNA strand forming hydrogen pairs with the adenosine motif. Using these models of RdRp, we employed them to screen the ZINC database of\u2009~\u200917 million molecules. Using docking and drug properties scoring, we narrowed down our selection to fourteen candidates. These were subjected to 200\u00a0ns simulations each underwent free energy calculations. We identified four hit compounds from the ZINC database that have similar binding poses to RTP while possessing lower overall binding free energies, with ZINC097971592 having a binding free energy two times lower than RTP.<\/jats:p>","DOI":"10.1038\/s41598-022-24695-4","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T13:43:57Z","timestamp":1669038237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations"],"prefix":"10.1038","volume":"12","author":[{"given":"Dylan","family":"Brunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Lakernick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"24695_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal, J. et al. Effectiveness of covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 385, 585\u2013594. https:\/\/doi.org\/10.1056\/NEJMoa2108891 (2021).","journal-title":"N. Engl. J. Med."},{"key":"24695_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","volume":"12","author":"G Kokic","year":"2021","unstructured":"Kokic, G. et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat. Commun. 12, 279. https:\/\/doi.org\/10.1038\/s41467-020-20542-0 (2021).","journal-title":"Nat. Commun."},{"key":"24695_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73641-9","author":"S Jockusch","year":"2020","unstructured":"Jockusch, S. et al. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by remdesivir. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-020-73641-9 (2020).","journal-title":"Sci. Rep."},{"key":"24695_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of covid-19\u2014Final report. N. Engl. J. Med. 383, 1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMoa2007764 (2020).","journal-title":"N. Engl. J. Med."},{"key":"24695_CR5","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1021\/acs.jproteome.0c00392","volume":"19","author":"MC Chien","year":"2020","unstructured":"Chien, M. C. et al. Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase, a key drug target for COVID-19. J. Proteome Res. 19, 4690\u20134697. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00392 (2020).","journal-title":"J. Proteome Res."},{"key":"24695_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/prp2.674","volume":"8","author":"JY Ju","year":"2020","unstructured":"Ju, J. Y. et al. Nucleotide analogues as inhibitors of SARS-CoV polymerase. Pharmacol. Res. Perspect. 8, 674. https:\/\/doi.org\/10.1002\/prp2.674 (2020).","journal-title":"Pharmacol. Res. Perspect."},{"key":"24695_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02439-0","author":"SO Aftab","year":"2020","unstructured":"Aftab, S. O. et al. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. J. Transl. Med. https:\/\/doi.org\/10.1186\/s12967-020-02439-0 (2020).","journal-title":"J. Transl. Med."},{"key":"24695_CR8","doi-asserted-by":"publisher","first-page":"e04502","DOI":"10.1016\/j.heliyon.2020.e04502","volume":"6","author":"J Ahmad","year":"2020","unstructured":"Ahmad, J., Ikram, S., Ahmad, F., Rehman, I. U. & Mushtaq, M. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp)\u2014A drug repurposing study. Heliyon 6, e04502. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04502 (2020).","journal-title":"Heliyon"},{"key":"24695_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1806112","author":"A Aktas","year":"2020","unstructured":"Aktas, A., Tuzun, B., Aslan, R., Sayin, K. & Ataseven, H. New anti-viral drugs for the treatment of COVID-19 instead of favipiravir. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1806112 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR10","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3389\/fmicb.2020.01796","volume":"11","author":"R Alexpandi","year":"2020","unstructured":"Alexpandi, R., De Mesquita, J. F., Pandian, S. K. & Ravi, A. V. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: An in silico analysis. Front. Microbiol. 11, 1796. https:\/\/doi.org\/10.3389\/fmicb.2020.01796 (2020).","journal-title":"Front. Microbiol."},{"key":"24695_CR11","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.33263\/briac105.64446459","volume":"10","author":"NA Al-Masoudi","year":"2020","unstructured":"Al-Masoudi, N. A., Elias, R. S. & Saeed, B. Molecular docking studies of some antiviral and antimalarial drugs via bindings to 3CL-protease and polymerase enzymes of the novel coronavirus (SARS-CoV-2). Biointerface Res. Appl. Chem. 10, 6444\u20136459. https:\/\/doi.org\/10.33263\/briac105.64446459 (2020).","journal-title":"Biointerface Res. Appl. Chem."},{"key":"24695_CR12","doi-asserted-by":"publisher","first-page":"581668","DOI":"10.3389\/fgene.2020.581668","volume":"11","author":"S Ao","year":"2020","unstructured":"Ao, S. et al. Identification of potential key agents for targeting RNA-dependent RNA polymerase of SARS-CoV-2 by integrated analysis and virtual drug screening. Front. Genet. 11, 581668. https:\/\/doi.org\/10.3389\/fgene.2020.581668 (2020).","journal-title":"Front. Genet."},{"key":"24695_CR13","doi-asserted-by":"publisher","first-page":"40445","DOI":"10.3390\/v12040445","volume":"12","author":"P Calligari","year":"2020","unstructured":"Calligari, P., Bobone, S., Ricci, G. & Bocedi, A. Molecular investigation of SARS-CoV-2 proteins and their interactions with antiviral drugs. Viruses-Basel 12, 40445. https:\/\/doi.org\/10.3390\/v12040445 (2020).","journal-title":"Viruses-Basel"},{"key":"24695_CR14","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760200207","author":"FMA da Silva","year":"2020","unstructured":"da Silva, F. M. A. et al. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). Mem. Inst. Oswaldo Cruz. https:\/\/doi.org\/10.1590\/0074-02760200207 (2020).","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"24695_CR15","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.3390\/ijms21103426","volume":"21","author":"JKR da Silva","year":"2020","unstructured":"da Silva, J. K. R., Figueiredo, P. L. B., Byler, K. G. & Setzer, W. N. Essential oils as antiviral agents, potential of essential oils to treat SARS-CoV-2 infection: An in-silico investigation. Int. J. Mol. Sci. 21, 3426. https:\/\/doi.org\/10.3390\/ijms21103426 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"24695_CR16","doi-asserted-by":"publisher","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","volume":"248","author":"AA Elfiky","year":"2020","unstructured":"Elfiky, A. A. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 248, 117477. https:\/\/doi.org\/10.1016\/j.lfs.2020.117477 (2020).","journal-title":"Life Sci."},{"key":"24695_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1761882","author":"AA Elfiky","year":"2020","unstructured":"Elfiky, A. A. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1761882 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.jiph.2020.10.015","volume":"13","author":"P Indu","year":"2020","unstructured":"Indu, P. et al. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. J. Infect. Public Health 13, 1856\u20131861. https:\/\/doi.org\/10.1016\/j.jiph.2020.10.015 (2020).","journal-title":"J. Infect. Public Health"},{"key":"24695_CR19","doi-asserted-by":"publisher","first-page":"e10480","DOI":"10.7717\/peerj.10480","volume":"8","author":"M Kandeel","year":"2020","unstructured":"Kandeel, M., Kitade, Y. & Almubarak, A. Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-Cov-2 (COVID-19) RNA-dependent RNA polymerase. Peerj 8, e10480. https:\/\/doi.org\/10.7717\/peerj.10480 (2020).","journal-title":"Peerj"},{"key":"24695_CR20","doi-asserted-by":"publisher","first-page":"34541","DOI":"10.1039\/d0ra06901a","volume":"10","author":"TA Mohamed","year":"2020","unstructured":"Mohamed, T. A. et al. Carotane sesquiterpenes from Ferula vesceritensis: In silico analysis as SARS-CoV-2 binding inhibitors. RSC Adv. 10, 34541\u201334548. https:\/\/doi.org\/10.1039\/d0ra06901a (2020).","journal-title":"RSC Adv."},{"key":"24695_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","volume":"163","author":"MSA Parvez","year":"2020","unstructured":"Parvez, M. S. A. et al. Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. Int. J. Biol. Macromol. 163, 1787\u20131797. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.098 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"24695_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1099\/jmm.0.001203","volume":"69","author":"R Pokhrel","year":"2020","unstructured":"Pokhrel, R., Chapagain, P. & Siltberg-Liberles, J. Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2. J. Med. Microbiol. 69, 864\u2013873. https:\/\/doi.org\/10.1099\/jmm.0.001203 (2020).","journal-title":"J. Med. Microbiol."},{"key":"24695_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jmv.26222","volume":"93","author":"ZJ Ruan","year":"2021","unstructured":"Ruan, Z. J. et al. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12). J. Med. Virol. 93, 389\u2013400. https:\/\/doi.org\/10.1002\/jmv.26222 (2021).","journal-title":"J. Med. Virol."},{"key":"24695_CR24","doi-asserted-by":"publisher","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","volume":"295","author":"EP Tchesnokov","year":"2020","unstructured":"Tchesnokov, E. P. et al. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. J. Biol. Chem. 295, 16156\u201316165. https:\/\/doi.org\/10.1074\/jbc.AC120.015720 (2020).","journal-title":"J. Biol. Chem."},{"key":"24695_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"CR Wu","year":"2020","unstructured":"Wu, C. R. et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B 10, 766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"24695_CR26","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1021\/acs.jproteome.0c00623","volume":"19","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. & Bourne, P. E. Structural insights into the binding modes of viral RNA-dependent RNA polymerases using a function-site interaction fingerprint method for RNA virus drug discovery. J. Proteome Res. 19, 4698\u20134705. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00623 (2020).","journal-title":"J. Proteome Res."},{"key":"24695_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1796804","author":"S Ahmed","year":"2020","unstructured":"Ahmed, S. et al. Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1796804 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1841026","author":"S Barage","year":"2020","unstructured":"Barage, S. et al. Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1841026 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5324560","volume":"2020","author":"LS Borquaye","year":"2020","unstructured":"Borquaye, L. S. et al. Alkaloids from Cryptolepis sanguinolenta as potential inhibitors of SARS-CoV-2 viral proteins: An in silico study. Biomed Res. Int. 2020, 1\u201314. https:\/\/doi.org\/10.1155\/2020\/5324560 (2020).","journal-title":"Biomed Res. Int."},{"key":"24695_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.sajb.2020.07.035","volume":"133","author":"D Dwarka","year":"2020","unstructured":"Dwarka, D., Agoni, C., Mellem, J. J., Soliman, M. E. & Baijnath, H. Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches. S. Afr. J. Bot. 133, 273\u2013284. https:\/\/doi.org\/10.1016\/j.sajb.2020.07.035 (2020).","journal-title":"S. Afr. J. Bot."},{"key":"24695_CR31","doi-asserted-by":"publisher","first-page":"584894","DOI":"10.3389\/fchem.2020.584894","volume":"8","author":"MA El Hassab","year":"2020","unstructured":"El Hassab, M. A., Shoun, A. A., Al-Rashood, S. T., Al-Warhi, T. & Eldehna, W. M. Identification of a new potential SARS-COV-2 RNA-dependent RNA polymerase inhibitor via combining fragment-based drug design, docking, molecular dynamics, and MM-PBSA calculations. Front. Chem. 8, 584894. https:\/\/doi.org\/10.3389\/fchem.2020.584894 (2020).","journal-title":"Front. Chem."},{"key":"24695_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1802346","author":"S Gul","year":"2020","unstructured":"Gul, S. et al. In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1802346 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR33","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1021\/acs.jpclett.0c01685","volume":"11","author":"JM Gutierrez-Villagomez","year":"2020","unstructured":"Gutierrez-Villagomez, J. M., Campos-Garcia, T., Molina-Torres, J., Lopez, M. G. & Vazquez-Martinez, J. Alkamides and piperamides as potential antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J. Phys. Chem. Lett. 11, 8008\u20138016. https:\/\/doi.org\/10.1021\/acs.jpclett.0c01685 (2020).","journal-title":"J. Phys. Chem. Lett."},{"key":"24695_CR34","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1080\/07391102.2020.1780947","volume":"39","author":"P Kar","year":"2020","unstructured":"Kar, P., Sharma, N. R., Singh, B., Sen, A. & Roy, A. Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. J. Biomol. Struct. Dyn. 39, 4774. https:\/\/doi.org\/10.1080\/07391102.2020.1780947 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12539-020-00381-9","volume":"12","author":"A Khan","year":"2020","unstructured":"Khan, A. et al. Phylogenetic analysis and structural perspectives of RNA-dependent RNA-polymerase inhibition from SARs-CoV-2 with natural products. Interdiscip. Sci.-Comput. Life Sci. 12, 335\u2013348. https:\/\/doi.org\/10.1007\/s12539-020-00381-9 (2020).","journal-title":"Interdiscip. Sci.-Comput. Life Sci."},{"key":"24695_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1819882","author":"O Mutlu","year":"2020","unstructured":"Mutlu, O. et al. Targeting SARS-CoV-2 Nsp12\/Nsp8 interaction interface with approved and investigational drugs: An in silico structure-based approach. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1819882 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR37","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/iub.2359","volume":"72","author":"N Narayanan","year":"2020","unstructured":"Narayanan, N. & Nair, D. T. Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from theSARS-CoV-2 virus. IUBMB Life 72, 2112\u20132120. https:\/\/doi.org\/10.1002\/iub.2359 (2020).","journal-title":"IUBMB Life"},{"key":"24695_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1822209","author":"G Ribaudo","year":"2020","unstructured":"Ribaudo, G. et al. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp). J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1822209 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1846624","author":"A Sharma","year":"2020","unstructured":"Sharma, A. et al. Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1846624 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1847688","author":"J Singh","year":"2020","unstructured":"Singh, J., Malik, D. & Raina, A. Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1847688 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR41","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1796810","author":"S Singh","year":"2020","unstructured":"Singh, S., Sk, M. F., Sonawane, A., Kar, P. & Sadhukhan, S. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2viaRNA-dependent RNA polymerase (RdRp) inhibition: An in-silico analysis. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1796810 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1813628","author":"Z Elkarhat","year":"2020","unstructured":"Elkarhat, Z., Charoute, H., Elkhattabi, L., Barakat, A. & Rouba, H. Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: Molecular docking, molecular dynamics simulations and MM-PBSA analyses. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1813628 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR43","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2014Ligand discovery for everyone. J. Chem. Inf. Model 55, 2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559 (2015).","journal-title":"J. Chem. Inf. Model"},{"key":"24695_CR44","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"WC Yin","year":"2020","unstructured":"Yin, W. C. et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368, 1499. https:\/\/doi.org\/10.1126\/science.abc1560 (2020).","journal-title":"Science"},{"key":"24695_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman, P. A. et al. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 33, 889\u2013897. https:\/\/doi.org\/10.1021\/ar000033j (2000).","journal-title":"Acc. Chem. Res."},{"key":"24695_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","volume":"320","author":"MP Jacobson","year":"2002","unstructured":"Jacobson, M. P., Friesner, R. A., Xiang, Z. & Honig, B. On the role of the crystal environment in determining protein side-chain conformations. J. Mol. Biol. 320, 597\u2013608. https:\/\/doi.org\/10.1016\/S0022-2836(02)00470-9 (2002).","journal-title":"J. Mol. Biol."},{"key":"24695_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins: Struct. Funct. Bioinform. 55, 351\u2013367. https:\/\/doi.org\/10.1002\/prot.10613 (2004).","journal-title":"Proteins: Struct. Funct. Bioinform."},{"key":"24695_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235 (2000).","journal-title":"Nucleic Acids Res."},{"key":"24695_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput.-Aided Mol. Des. 27, 221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8 (2013).","journal-title":"J. Comput.-Aided Mol. Des."},{"key":"24695_CR50","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430 (2004).","journal-title":"J. Med. Chem."},{"key":"24695_CR51","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J. Med. Chem. 49, 6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o (2006).","journal-title":"J. Med. Chem."},{"key":"24695_CR52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"JR Greenwood","year":"2010","unstructured":"Greenwood, J. R., Calkins, D., Sullivan, A. P. & Shelley, J. C. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J. Comput. Aided Mol. Des. 24, 591\u2013604. https:\/\/doi.org\/10.1007\/s10822-010-9349-1 (2010).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"24695_CR53","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C. et al. Epik: A software program for pKaprediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681\u2013691. https:\/\/doi.org\/10.1007\/s10822-007-9133-z (2007).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"24695_CR54","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s (2004).","journal-title":"J. Med. Chem."},{"key":"24695_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281\u2013296. https:\/\/doi.org\/10.1021\/acs.jctc.5b00864 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"24695_CR56","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1021\/ct300203w","volume":"8","author":"D Shivakumar","year":"2012","unstructured":"Shivakumar, D., Harder, E., Damm, W., Friesner, R. A. & Sherman, W. Improving the prediction of absolute solvation free energies using the next generation OPLS force field. J. Chem. Theory Comput. 8, 2553\u20132558. https:\/\/doi.org\/10.1021\/ct300203w (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"24695_CR57","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen, W. L., Maxwell, D. S. & Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118, 11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760 (1996).","journal-title":"J. Am. Chem. Soc."},{"key":"24695_CR58","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A 105, 9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w (2001).","journal-title":"J. Phys. Chem. A"},{"key":"24695_CR59","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen, W. L., Maxwell, D. S. & TiradoRives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118, 11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760 (1996).","journal-title":"J. Am. Chem. Soc."},{"key":"24695_CR60","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1080\/07391102.2018.1513378","volume":"37","author":"D Montgomery","year":"2019","unstructured":"Montgomery, D., Campbell, A., Sullivan, H.-J. & Wu, C. Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity. J. Biomol. Struct. Dyn. 37, 3206\u20133225. https:\/\/doi.org\/10.1080\/07391102.2018.1513378 (2019).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24695_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jmgm.2017.05.010","volume":"75","author":"S Sader","year":"2017","unstructured":"Sader, S., Cai, J., Muller, A. C. G. & Wu, C. Can human allergy drug fexofenadine, an antagonist of histamine (H1) receptor, be used to treat dog and cat? Homology modeling, docking and molecular dynamic simulation of three H1 receptors in complex with fexofenadine. J. Mol. Graph. Model. 75, 106\u2013116. https:\/\/doi.org\/10.1016\/j.jmgm.2017.05.010 (2017).","journal-title":"J. Mol. Graph. Model."},{"key":"24695_CR62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jmgm.2016.11.019","volume":"72","author":"S Sader","year":"2017","unstructured":"Sader, S. & Wu, C. Computational analysis of Amsacrine resistance in human topoisomerase II alpha mutants (R487K and E571K) using homology modeling, docking and all-atom molecular dynamics simulation in explicit solvent. J. Mol. Graph. Model. 72, 209\u2013219. https:\/\/doi.org\/10.1016\/j.jmgm.2016.11.019 (2017).","journal-title":"J. Mol. Graph. Model."},{"key":"24695_CR63","unstructured":"Bowers, K. J. et al. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing (Association for Computing Machinery, 2006)."},{"key":"24695_CR64","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/jcc.21237","volume":"30","author":"AG Bailey","year":"2009","unstructured":"Bailey, A. G. & Lowe, C. P. MILCH SHAKE: An efficient method for constraint dynamics applied to alkanes. J. Comput. Chem. 30, 2485\u20132493. https:\/\/doi.org\/10.1002\/jcc.21237 (2009).","journal-title":"J. Comput. Chem."},{"key":"24695_CR65","doi-asserted-by":"publisher","unstructured":"Shan, Y. B., Klepeis, J. L., Eastwood, M. P., Dror, R. O. & Shaw, D. E. Gaussian split Ewald: A fast Ewald mesh method for molecular simulation. J. Chem. Phys. 122, 054101doi:https:\/\/doi.org\/10.1063\/1.1839571 (2005).","DOI":"10.1063\/1.1839571"},{"key":"24695_CR66","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1063\/1.472005","volume":"105","author":"SJ Stuart","year":"1996","unstructured":"Stuart, S. J., Zhou, R. H. & Berne, B. J. Molecular dynamics with multiple time scales: The selection of efficient reference system propagators. J. Chem. Phys. 105, 1426\u20131436. https:\/\/doi.org\/10.1063\/1.472005 (1996).","journal-title":"J. Chem. Phys."},{"key":"24695_CR67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/jcc.10402","volume":"25","author":"M Ikeguchi","year":"2004","unstructured":"Ikeguchi, M. Partial rigid-body dynamics in NPT, NPAT and NP gamma T ensembles for proteins and membranes. J. Comput. Chem. 25, 529\u2013541. https:\/\/doi.org\/10.1002\/jcc.10402 (2004).","journal-title":"J. Comput. Chem."},{"key":"24695_CR68","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber, G. & Langer, T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 45, 160\u2013169. https:\/\/doi.org\/10.1021\/ci049885e (2005).","journal-title":"J. Chem. Inf. Model."},{"key":"24695_CR69","unstructured":"QikProp v. Schr\u00f6dinger Release 2021-4 (2021)."},{"key":"24695_CR70","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 20 model: A next generation energy model for high resolution protein structure modeling. Proteins Struct. Funct. Bioinform. 79, 2794. https:\/\/doi.org\/10.1002\/prot.23106 (2011).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"24695_CR71","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/bioinformatics\/btr168","volume":"27","author":"A Bakan","year":"2011","unstructured":"Bakan, A., Meireles, L. M. & Bahar, I. ProDy: Protein dynamics inferred from theory and experiments. Bioinformatics 27, 1575\u20131577. https:\/\/doi.org\/10.1093\/bioinformatics\/btr168 (2011).","journal-title":"Bioinformatics"},{"key":"24695_CR72","doi-asserted-by":"publisher","first-page":"100461","DOI":"10.1016\/j.imu.2020.100461","volume":"21","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. In silico identification of drug candidates against COVID-19. Inform. Med. Unlocked 21, 100461. https:\/\/doi.org\/10.1016\/j.imu.2020.100461 (2020).","journal-title":"Inform. Med. Unlocked"},{"key":"24695_CR73","doi-asserted-by":"publisher","first-page":"26792","DOI":"10.1039\/d0ra04743k","volume":"10","author":"S Koulgi","year":"2020","unstructured":"Koulgi, S., Jani, V., Uppuladinne, M. V. N., Sonavane, U. & Joshi, R. Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. RSC Adv. 10, 26792\u201326803. https:\/\/doi.org\/10.1039\/d0ra04743k (2020).","journal-title":"RSC Adv."},{"key":"24695_CR74","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1021\/acs.jpcb.0c04198","volume":"124","author":"L Zhang","year":"2020","unstructured":"Zhang, L. & Zhou, R. Structural basis of the potential binding mechanism of remdesivir to SARS-CoV-2 RNA-dependent RNA polymerase. J. Phys. Chem. B 124, 6955\u20136962. https:\/\/doi.org\/10.1021\/acs.jpcb.0c04198 (2020).","journal-title":"J. Phys. Chem. B"},{"key":"24695_CR75","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"24695_CR76","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.isci.2020.102021","volume":"24","author":"C Gorgulla","year":"2021","unstructured":"Gorgulla, C. et al. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience 24, 102021\u2013102021. https:\/\/doi.org\/10.1016\/j.isci.2020.102021 (2021).","journal-title":"iScience"},{"key":"24695_CR77","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1002\/anie.201600190","volume":"55","author":"I Sosi\u010d","year":"2016","unstructured":"Sosi\u010d, I. et al. Nonpeptidic selective inhibitors of the chymotrypsin-like (\u03b25 i) subunit of the immunoproteasome. Angew. Chem. Int. Ed. 55, 5745\u20135748. https:\/\/doi.org\/10.1002\/anie.201600190 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"24695_CR78","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.22146\/ijc.56120","volume":"20","author":"M Arba","year":"2020","unstructured":"Arba, M. et al. Virtual screening of the Indonesian medicinal plant and zinc databases for potential inhibitors of the RNA-dependent RNA polymerase (RdRp) of 2019 novel coronavirus. Indones. J. Chem. 20, 1430. https:\/\/doi.org\/10.22146\/ijc.56120 (2020).","journal-title":"Indones. J. Chem."},{"key":"24695_CR79","doi-asserted-by":"publisher","first-page":"104156","DOI":"10.1016\/j.compbiomed.2020.104156","volume":"129","author":"M Arba","year":"2021","unstructured":"Arba, M., Wahyudi, S. T., Brunt, D. J., Paradis, N. & Wu, C. Mechanistic insight on the remdesivir binding to RNA-dependent RNA polymerase (RdRp) of SARS-cov-2. Comput. Biol. Med. 129, 104156. https:\/\/doi.org\/10.1016\/j.compbiomed.2020.104156 (2021).","journal-title":"Comput. Biol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24695-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24695-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24695-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T15:07:50Z","timestamp":1669129670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24695-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24695"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24695-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"27 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19986"}}